Telangana Lifesciences Advisory Committee Reconstituted


Minister KTR today chaired the first meeting of the reconstituted Lifesciences advisory committee. Government has reconstituted the lifesciences advisory committee with members of industry and academia with a term of two years. Mr. Satish Reddy, Chairman, Dr. Reddy’s Laboratories will be the Chairman, Ms. Mahima Datla, Managing Director of Biological E will serve as Vice-Chairman and Director Life Sciences Government of Telangana will be convener for the committee.

The objective of the Lifesciences advisory committee is to serve a structured interface between Government, Industry and Academia.
The first committee was formed in the year 2016 under the chairmanship of Prof. D. Balasubramian, Director Emeritus (Research), LV Prasad Eye Institute and Mr. Satish Reddy as the Vice Chairman. This committee advised the Government on aspects like improving Ease of Doing Business (EODB) specific to the lifesciences sector at various state level agencies, which were successfully implemented. Further, the committee supported the planning of Hyderabad Pharma City, organization of BioAsia-State’s flagship event and various other initiatives.
The reconstituted committee consists of officials from industries department, leaders from industry and research institute covering Pharmaceuticals, Biotechnology, Medical Devices, Digital Health, etc (List enclosed)
Minister KTR said that, “It is our vision to grow the Lifesciences industry from USD 50 Bn to USD 100 Bn and creating 400,000 new jobs in this decade.

Briefing on the efforts already undertaken by the State Government to strengthen the sector, he requested the committee to play in pivotal role in advising the Government on the initiatives that can help consolidate Hyderabad’s leadership position in life sciences.”
The members brainstormed and deliberated on different areas such as industry-academia collaboration, strengthening public health infrastructure, development of Genome Valley with focus on innovation, funding to start-ups, skill development, pharma services driven ecosystem, diagnostics and digital medicine.